(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIAISON IQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIAISON IQ

ST13

US500000097074035

Class

1, 5, 9, 10

Filing

97074035

Registration

7003667

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

03/21/2023

Trademark type

Word

Nice classes

1, 5, 9, 10

Filing date

10/14/2021

Registration date

03/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/21/2023

Last transaction

03/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

09

Owner location

SALUGGIA, VERCELLI, IT

Examiner

SALES, HEATHER

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

DIASORIN S.P.A.
DIASORIN INC.

Representatives

Jeffrey B. Sladkus, Esq. THE SLADKUS LAW GROUP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals for use in science; chemical diagnostic reagents for scientific purposes; Diagnostic preparationsother than for medical or veterinary purposes; diagnostic substancesother than for medical or veterinary use; Reagent bearing diagnostic strips for testing of infectious diseases and organic moleculesother than for medical or veterinary use; diagnostic testing materialsother than for medical use in the nature of reagent bearing diagnostic strips for testing saliva; Control preparationschemical control solutions used in in-vitro diagnostic testingscreeningconfirmation and analysis for laboratory or research use; diagnostic reagents and chemical reagents for laboratory or research purposes; chemical control solutions used in diagnostic test kits for laboratory or research purposes; chemically treated non-medical test strips for laboratory or research purposes; diagnostic preparations for laboratory or research use; diagnostic preparations for use in assessment of toxicological property of chemical compounds and mixture for scientific use; diagnostic biomarkers for analyticalresearch and scientific use; diagnostic preparations for in vitro testing for scientific use

Class 5

Diagnostic preparations for medical and veterinary purposes; Medical diagnostic test reagents for testing body fluids for veterinary use; medical diagnostic test reagents for testing body fluids for medical purposes; Diagnostic agents for medical use; Chemical reagents for medical or veterinary purposes; diagnostic kits comprising medical diagnostic bioreagents for extractingtesting and analyzing body fluids; diagnostic test kits comprising medical diagnostic reagents and assays for testing of bodily fluids for use in diseases detectioninfectious diseases and detection of biological parameters; Diagnostic testing materials for medical usemedical diagnostic test strips for use in the field of infectious deseases and detection of biological parameters; medical diagnostic test strips for blood analysis; virus testing preparations for medical use; medical diagnostic assays for medical use; in vitro medical diagnostic teststest strips; in vitro medical diagnostic assays for medical use; in vitro medical diagnostic test kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; in vitro medical diagnostic test strips for blood analysis; in vitro medical diagnostic reagents; medical diagnostics tests strips for the detectiondiagnosisscreeningconfirmation of viruses and infections; reagents and test strips for medical purposes for use in detecting the presence of nucleic acid targetsindicators of diseasessuch indicators including enzymesantigensantibodies and nucleic acids; immunoassay reagents for medical use; biochemical preparations for medical or veterinary purposes for detection of infectious diseases and biological parameters; bacterial preparations for medical and veterinary use

Class 9

Downloadable computer software mobile applications for use in diagnosing individuals; downloadable computer software for medical diagnostics and for use to operate diagnostic apparatuses not for medical purpose; downloadable portable and cloud-connected POC (Point of care) immunodiagnostic software platform for diagnosing individuals; Downloadable computer software and hardware for the designcreation and control of tools for medical diagnosticsdata-processing softwareapparatusequipmenthardware and computers for diagnostics; data storageprocessing and transmission apparatus for diagnostic purposeblank tapes for storage of computer data; electronic book readers for diagnostic purpose; PC tablets used for test and diagnostic purpose; Video monitors; structural parts and fittings for the aforementioned goods where applicableall applied in the diagnostic field; Testing apparatus not for medical purposesapparatus for testing liquids and solids; testing machines and instruments for diagnostic purposeother than for medical useapparatus for testing liquids and solidscomposed of PC tablets and optical reader; research laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids

Class 10

Diagnostic testing apparatus for medical purposes for testing biomarkers and other biomolecules; medical diagnostic apparatus for medical purposes; tools for medical diagnosticsmedical diagnostic apparatus for testing for viruses and infection diseases; medical devices for diagnosing viruses; medical testing equipmentmedical device for detecting antibodies against SARS-CoV-2; medical apparatus for use in medical analysis for analyzing bacteria; Electronic analyzers for bacterial identification for medical purposes; apparatus for taking blood samples; apparatus for taking body fluid samples; Point of Care (POC) diagnosticexaminationmonitoring equipmentrespiratory equipment and monitors therefor; Point of care (POC) immunochemical testing apparatus for carrying-out diagnostic tests for medical purposes; diagnostic apparatus for the identification of specific antibodies against SARS-CoV-2 in capillary blood samples; medical diagnostic apparatus for the identification of antigens to diagnose Covid-19 via nasal swab; diagnostic apparatus for the identification of virus and infectious diseases; radiological diagnostic imaging apparatus for medical purposes in the field of immunochemistry; medical diagnostic apparatus for testing for viruses; apparatus for DNA and RNA testing for medical purposes; Syringes for injections; syringes for medical purposes; hypodermic syringes; extraction medical syringes; disposable hypodermic syringes for medical use; medical syringe needles; needles for medical purposes; medical micro-needling devices

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/03/2023

PUBO

PUBLISHED FOR OPPOSITION

01/03/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/14/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/29/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

11/18/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/18/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

11/18/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/18/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/19/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/19/2022

ALIE

ASSIGNED TO LIE

10/19/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/08/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/16/2022

GNRT

NON-FINAL ACTION E-MAILED

03/16/2022

CNRT

NON-FINAL ACTION WRITTEN

03/16/2022

DOCK

ASSIGNED TO EXAMINER

03/15/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/03/2021

NWAP

NEW APPLICATION ENTERED

10/18/2021

Continuous trademark protection

Get notified about every new filing that threatens LIAISON IQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.